November 20, 2025 – FDA Clearance for Low Back Pain Device and more news…

Published: November 20, 2025

November 20, 2025

Focused Ultrasound for Low Back Pain: First FDA Clearance

FUSMobile has announced that its Neurolyser XR system has been granted clearance by the US Food and Drug Administration (FDA) for the treatment of chronic low back pain.
The device, which uses focused ultrasound to ablate sensory nerves in the spinal facet joints, is also approved in Europe, Canada, and the UK.

Foundation Hosts Workshop on Focused Ultrasound to Treat Epilepsy

A 1.5-day workshop was recently held to accelerate the development of focused ultrasound as a safe and effective therapy for treating epilepsy.
A white paper summarizing the event will be made available in the coming months.

Podcast: One Patient’s Uterine Adenomyosis Journey

Dr. Vanda Corbett traveled to China to have focused ultrasound for her adenomyosis – a common uterine condition that can cause debilitating pain.
She learned of the noninvasive treatment option thanks to one Foundation team member’s podcast appearance.

Listen to the Episode

A Life Reclaimed from Essential Tremor: Melissa Finds Hope Through Focused Ultrasound

Diagnosed in childhood, the condition disrupted Melissa's daily routines and her sense of independence.
Everything changed after she underwent bilateral focused ultrasound treatment, calling it “a complete miracle.”

Read Her Story

Podcast: How Focused Ultrasound is Rewriting Immunotherapy

The Scoop on Ultrasound podcast featured Natasha Sheybani, PhD, assistant professor of biomedical engineering at the University of Virginia.
Learn how innovation and translational research are advancing cancer treatments and what the future of noninvasive, immune-activating therapy could mean for patients.

Listen Now

October 2025 Meeting Reports

Eight recent conferences featured focused ultrasound presentations.
Topics included Parkinson’s disease and other movement disorders, cell and gene therapy, prostate cancer, neurosurgery, neuro-oncology, and more.

Read the Reports

Profound Medical Announces Expansion in Several Markets

This month, Profound Medical announced major distribution agreements to expand its reach to Australia, New Zealand, Saudi Arabia, and Canada.
Profound has two therapeutic ultrasound devices on the market – the TULSA-PRO and the Sonalleve.

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

Focused Ultrasound on Not Your Mother’s Menopause Podcast | Pelvic Pain: A Woman's Journey to Innovative Treatment for Adenomyosis with Dr. Vanda Corbett | Listen to Vanda’s Curing with Sound Podcast, too!

Learn about the Co-Inventor of Histotripsy, Zhen Xu, PhD | Treating Cancer with Sound Waves

See Recent News

Events

November 20-22, 2025 World Society for Stereotactic and Functional Neurosurgery (WSSFN) Interim Meeting, Buenos Aires, Argentina

November 27-28, 2025 Brainbox Initiative Workshop: Introduction to Non-Invasive Brain Stimulation, Cardiff, United Kingdom

November 30-December 4, 2025 Radiological Society of North America (RSNA), Chicago, Illinois, USA

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“Focused ultrasound treatment has impacted every aspect of my life. I went from having chronic pain almost every day to just waking up and actually going about my day and feeling normal. It's absolutely incredible. I encourage anybody if they fit the criteria to have focused ultrasound. Just go for it, because it could actually change your life as well.”

‒ Vanda, after undergoing focused ultrasound in China for her adenomyosis

November 20, 2025 – FDA Clearance for Low Back Pain Device and more news…

Contact

Terms of Use